Extended real-world experience with the ILUVIEN® (fluocinolone acetonide) implant in the United Kingdom: 3-year results from the Medisoft® audit study

BACKGROUND: This study aimed to assess the long-term effectiveness of the 0.2 μg/day fluocinolone acetonide (FAc) implant over ≥3 years for patients with diabetic macular oedema. METHODS: A retrospective audit of pseudo-anonymised data from patients with chronic diabetic macular oedema (cDMO) and tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bailey, Clare, Chakravarthy, Usha, Lotery, Andrew, Menon, Geeta, Talks, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107780/
https://www.ncbi.nlm.nih.gov/pubmed/33972705
http://dx.doi.org/10.1038/s41433-021-01542-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107780/
https://www.ncbi.nlm.nih.gov/pubmed/33972705
http://dx.doi.org/10.1038/s41433-021-01542-w

Ejemplares similares